M
27.35
0.26 (0.96%)
| Penutupan Terdahulu | 27.09 |
| Buka | 27.10 |
| Jumlah Dagangan | 1,135,950 |
| Purata Dagangan (3B) | 372,231 |
| Modal Pasaran | 1,193,950,592 |
| Harga / Buku (P/B) | 3.87 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 May 2023 |
| EPS Cair (TTM) | -2.30 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 18.32% |
| Nisbah Semasa (MRQ) | 21.11 |
| Aliran Tunai Operasi (OCF TTM) | -139.78 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -102.40 M |
| Pulangan Atas Aset (ROA TTM) | -19.85% |
| Pulangan Atas Ekuiti (ROE TTM) | -30.64% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | MoonLake Immunotherapeutics | Menaik | Menurun |
AISkor Stockmoo
1.3
| Konsensus Penganalisis | -1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.0 |
| Purata | 1.25 |
|
MoonLake Immunotherapeutics is a clinical-stage biotechnology company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Mid Growth |
| % Dimiliki oleh Orang Dalam | 15.34% |
| % Dimiliki oleh Institusi | 96.70% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 35.00 (Oppenheimer, 27.97%) | Beli |
| Median | 27.50 (0.55%) | |
| Rendah | 10.00 (Goldman Sachs, -63.44%) | Jual |
| Purata | 24.00 (-12.25%) | |
| Jumlah | 4 Beli, 1 Pegang, 1 Jual | |
| Harga Purata @ Panggilan | 17.33 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Oppenheimer | 24 Feb 2026 | 35.00 (27.97%) | Beli | 18.07 |
| BTIG | 23 Feb 2026 | 30.00 (9.69%) | Beli | 18.07 |
| 09 Feb 2026 | 24.00 (-12.25%) | Beli | 15.75 | |
| Needham | 23 Feb 2026 | 25.00 (-8.59%) | Beli | 18.07 |
| RBC Capital | 20 Feb 2026 | 12.00 (-56.12%) | Pegang | 18.07 |
| HC Wainwright & Co. | 03 Feb 2026 | 32.00 (17.00%) | Beli | 15.37 |
| 09 Jan 2026 | 32.00 (17.00%) | Beli | 18.49 | |
| Goldman Sachs | 15 Jan 2026 | 10.00 (-63.44%) | Jual | 16.35 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |